HIGHLIGHTS
- who: Jun Wang from the Temple University, United States have published the research: Cardiac regeneration: Options for repairing the injured heart, in the Journal: (JOURNAL)
SUMMARY
Human pluripotent stem_cells (hPSCs)-derived cardiomyocytes (hPSC-CMs) have been extensively used for disease modeling and drug screening in CVD. With the advancement of hPSC-CM research and cardiac organoid engineering, it has become possible to graft stem_cell-derived-CMs into the injured heart, providing directions for Frontiers in Cardiovascular Medicine frontiersin.org 10.3389/fcvm.2022.981982 optimizing these approaches. In this review, the authors list . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.